Oregon Bio Digital 2020: Amplifying Diversity of Discovery, Access and Economics happens over three half-days Nov. 17, 18, 19 and brings together investors, start-up entrepreneurs, executives, researchers, policymakers and bio-supply chain
Synthetic biology startup AbSci raises $65M to expand ‘Protein Printing’ tech By Taylor Soper – https://www.geekwire.com/2020/synthetic-biology-startup-absci-raises-65m-expand-protein-printing-tech/ Vancouver, Wash.-based biotech company AbSci raised an additional $65 million to help grow its synthetic biology
By Corina Stef – https://www.cpexecutive.com/post/top-5-office-projects-under-construction-in-portland/ Top 5 Office Projects Under Construction in Portland Based on Yardi Matrix data, 2.5 million square feet of office space was underway as of October, including
By Dave Sebastian – https://www.marketscreener.com/quote/stock/THERMO-FISHER-SCIENTIFIC-14623/news/Thermo-Fisher-Scientific-Expects-2020-Revenue-to-Grow-20-31583605/ Thermo Fisher Scientific Inc. executives said the company expects 2020 revenue to grow 20% to about $30.52 billion, its first full-year outlook since it withdrew
— Veklury Is First and Only FDA-Approved Treatment for COVID-19 in the United States — — Veklury Shortened Time to Recovery By Five Days in Hospitalized COVID-19 Patients — Gilead
Credit: https://www.cnbc.com/2020/10/09/covid-19-drives-historic-demand-for-life-sciences-real-estate-.html All the fundamentals are aligning for the life sciences industry, as Covid-19 accelerates already growing demand for real estate in the sector. Rents are rising for lab space,
The Oregon Bioscience Association invites high school through post-doctoral researchers as well as bio entrepreneurs leading early- and later-stage startups from Oregon and Southwest Washington to compete in Oregon Bio’s
UO researcher’s work drives launch of spin-off, Penderia Technologies By Matt Sayre, Contributor, The Register-Guard The Phil and Penny Knight Campus for Accelerating Scientific Impact is not scheduled to open officially until
Oregon Bio recently caught up with Sedia Biosciences Corp.’s two founders, Roger Gale and Ron Mink, Ph.D. to learn more – not only about how its coping with Covid-19 impacts
Last Thursday, Oregon Bio culled together about 100 industry pros for a Diversity Dialogue around equity and inclusion. Participants from a broad range of multi-cultural backgrounds and experiences engaged with
On Thursday, July 30, BIPOC leaders and life science experts will convene for Diversity Dialogue: #BeTheChange. The panelists are respected bio professionals Dr. Emmanuel Akporiaye, founder of Veana Therapeutics; Ndongo
Oregon Bioscience Association Copyright 2024. All Rights Reserved.